Pharmaceuticals, Biotechnology and Life Sciences
BOSTON–(BUSINESS WIRE)–Decibel Therapeutics, a clinical-stage biotechnology company developing novel therapeutics for hearing loss and balance disorders, will provide a corporate…
Alternative to Faslodex® is the only formulation of Fulvestrant Injection stable at room temperature LAKE ZURICH, Ill.–(BUSINESS WIRE)–Fresenius Kabi announced…
Funding will support clinical development of stem cell-derived platelet technology platform CAMBRIDGE, Mass.–(BUSINESS WIRE)–Platelet BioGenesis, Inc. (PBG), the leader in…
Completed enrollment in AXA1125 and AXA1957 study in adults with NAFLD Initiated enrollment of AXA1957 study in adolescents with NAFLD…
YTX-7739 represents a novel, first-in-class, potentially disease-modifying therapy Data from Phase 1 study expected in the first quarter of 2020…
LEXINGTON, Mass.–(BUSINESS WIRE)–#aldeyratherapeutics–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that Todd C. Brady, M.D., Ph.D., President and CEO of…
CARLSBAD, Calif.–(BUSINESS WIRE)–$LCTX #AMD—Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies…
Median overall survival for ADXS-PSA in combination with KEYTRUDA® increased to 33.6 months from previously reported 21.1 months PRINCETON, N.J.–(BUSINESS…
AUSTIN, Texas & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Genprex, Inc. (NASDAQ: GNPX), a clinical-stage company and leader in gene therapy using non-viral vector…
Nevakar, ophthalmology specialist pharmaceutical company has entered into a $17.5 million product financing agreement with an affiliate of H.I.G. Capital Partners, L.P. for the continued development of five differentiated, sterile injectable products.